| |
| |
|
| Insider
Information: |
Tcg Opportunity Iii Gp, Llc |
| Relationship: |
|
| City: |
Building D, Suite Dm-900 |
| State: |
CA |
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
2 |
|
| Direct
Shares |
0 |
|
|
Indirect Shares
|
23,000,565 |
|
|
| Direct
Value |
$0 |
|
|
|
Indirect Value
|
$1,540 |
|
|
| Total
Shares |
23,000,565 |
|
|
| Total
Value |
$1,540 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
0
|
0
|
|
Stock
price went up :
|
|
|
| Stock
price went down : |
|
|
| |
|
|
|
Gain/Loss Ratio : |
0.0
|
0.0
|
| Percentage
Gain/Loss : |
0.0%
|
0.0%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
Ngm Biopharmaceuticals Inc |
NGM |
10% Owner |
2024-04-05 |
0 |
2024-04-05 |
1,000 |
Premium* |
|
|
Tenaya Therapeutics, Inc. |
TNYA |
|
2022-11-21 |
0 |
2024-02-12 |
22,999,565 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
25 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 1 of 1
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| NGM |
Ngm Biopharmaceuticals In... |
10% Owner |
– – • |
2024-04-05 |
4 |
A |
$0.00 |
$0 |
I/I |
1,000 |
1,000 |
0 |
- |
|
| NGM |
Ngm Biopharmaceuticals In... |
10% Owner |
– – • |
2024-04-05 |
4 |
D |
$0.00 |
$0 |
I/I |
(10,640,080) |
0 |
0 |
- |
|
| NGM |
Ngm Biopharmaceuticals In... |
10% Owner |
– – • |
2024-04-05 |
4 |
D |
$0.00 |
$0 |
D/D |
(11,103,333) |
0 |
0 |
- |
|
| TNYA |
Tenaya Therapeutics, Inc. |
|
– – • |
2024-02-12 |
4 |
B |
$4.50 |
$9,999,999 |
I/I |
2,222,222 |
13,599,275 |
0.01 |
- |
|
| NGM |
Ngm Biopharmaceuticals In... |
|
– – • |
2023-11-16 |
4 |
B |
$0.62 |
$3,627 |
I/I |
5,840 |
949,862 |
0.01 |
% |
|
| NGM |
Ngm Biopharmaceuticals In... |
|
– – • |
2023-11-15 |
4 |
B |
$0.71 |
$11,880 |
I/I |
16,791 |
944,022 |
0.01 |
% |
|
| TNYA |
Tenaya Therapeutics, Inc. |
10% Owner |
– – • |
2023-03-10 |
4 |
B |
$2.60 |
$17,596 |
I/I |
6,779 |
11,377,053 |
1.5 |
- |
|
| TNYA |
Tenaya Therapeutics, Inc. |
10% Owner |
– – • |
2023-02-08 |
4 |
B |
$2.60 |
$3,900,000 |
I/I |
1,500,000 |
11,370,274 |
1.5 |
- |
|
| NGM |
Ngm Biopharmaceuticals In... |
10% Owner |
– – • |
2023-01-31 |
4 |
B |
$5.00 |
$883,403 |
I/I |
176,730 |
927,231 |
1.5 |
% |
|
| NGM |
Ngm Biopharmaceuticals In... |
10% Owner |
– – • |
2023-01-30 |
4 |
B |
$5.00 |
$37,707 |
I/I |
7,542 |
750,501 |
1.5 |
% |
|
| NGM |
Ngm Biopharmaceuticals In... |
10% Owner |
– – • |
2023-01-23 |
4 |
B |
$5.00 |
$49,494 |
I/I |
9,900 |
742,959 |
1.5 |
% |
|
| NGM |
Ngm Biopharmaceuticals In... |
10% Owner |
– – • |
2023-01-20 |
4 |
B |
$5.00 |
$2,498 |
I/I |
500 |
733,059 |
1.42 |
% |
|
| TNYA |
Tenaya Therapeutics, Inc. |
10% Owner |
– – • |
2023-01-19 |
4 |
B |
$2.50 |
$174,201 |
I/I |
69,739 |
9,870,274 |
1.5 |
- |
|
| NGM |
Ngm Biopharmaceuticals In... |
10% Owner |
– – • |
2023-01-19 |
4 |
B |
$5.00 |
$188,105 |
I/I |
37,639 |
732,559 |
1.5 |
% |
|
| TNYA |
Tenaya Therapeutics, Inc. |
10% Owner |
– – • |
2023-01-18 |
4 |
B |
$2.52 |
$341,432 |
I/I |
135,688 |
9,800,535 |
1.5 |
- |
|
| TNYA |
Tenaya Therapeutics, Inc. |
10% Owner |
– – • |
2023-01-17 |
4 |
B |
$2.49 |
$123,395 |
I/I |
49,463 |
9,664,847 |
1.5 |
- |
|
| NGM |
Ngm Biopharmaceuticals In... |
10% Owner |
– – • |
2023-01-12 |
4 |
B |
$4.95 |
$26,603 |
I/I |
5,378 |
694,920 |
1.5 |
% |
|
| NGM |
Ngm Biopharmaceuticals In... |
10% Owner |
– – • |
2023-01-11 |
4 |
B |
$4.76 |
$994,840 |
I/I |
209,000 |
689,542 |
1.5 |
% |
|
| NGM |
Ngm Biopharmaceuticals In... |
10% Owner |
– – • |
2023-01-10 |
4 |
B |
$4.84 |
$484,519 |
I/I |
100,070 |
480,542 |
1.5 |
% |
|
| NGM |
Ngm Biopharmaceuticals In... |
10% Owner |
– – • |
2022-12-12 |
4 |
B |
$4.98 |
$1,493 |
I/I |
300 |
380,472 |
1.42 |
% |
|
| NGM |
Ngm Biopharmaceuticals In... |
10% Owner |
– – • |
2022-11-22 |
4 |
B |
$5.00 |
$21,646 |
I/I |
4,330 |
380,172 |
1.5 |
% |
|
| TNYA |
Tenaya Therapeutics, Inc. |
10% Owner |
– – • |
2022-11-21 |
4 |
B |
$2.60 |
$24,999,998 |
I/I |
9,615,384 |
9,615,384 |
1.5 |
- |
|
| NGM |
Ngm Biopharmaceuticals In... |
10% Owner |
– – • |
2022-11-21 |
4 |
B |
$5.00 |
$179,942 |
I/I |
35,997 |
375,842 |
1.5 |
% |
|
| NGM |
Ngm Biopharmaceuticals In... |
10% Owner |
– – • |
2022-11-04 |
4 |
B |
$4.72 |
$165,320 |
I/I |
35,058 |
339,845 |
1.5 |
% |
|
| NGM |
Ngm Biopharmaceuticals In... |
10% Owner |
– – • |
2022-11-03 |
4 |
B |
$4.99 |
$519,107 |
I/I |
104,090 |
304,787 |
1.5 |
% |
|
25 Records found
|
1
|
Page 1 of 1 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
